163 related articles for article (PubMed ID: 38779986)
1. The role of interleukin-36 in health and disease states.
Sugiura K; Fujita H; Komine M; Yamanaka K; Akiyama M
J Eur Acad Dermatol Venereol; 2024 May; ():. PubMed ID: 38779986
[TBL] [Abstract][Full Text] [Related]
2. Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions.
Sachen KL; Arnold Greving CN; Towne JE
Cytokine; 2022 Aug; 156():155897. PubMed ID: 35679693
[TBL] [Abstract][Full Text] [Related]
3. Emerging Role of the IL-36/IL-36R Axis in Multiple Inflammatory Skin Diseases.
Ahmad F; Alam MA; Ansari AW; Jochebeth A; Leo R; Al-Abdulla MN; Al-Khawaga S; AlHammadi A; Al-Malki A; Al Naama K; Ahmad A; Buddenkotte J; Steinhoff M
J Invest Dermatol; 2024 Feb; 144(2):206-224. PubMed ID: 38189700
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-36: Structure, Signaling and Function.
Zhou L; Todorovic V
Adv Exp Med Biol; 2021; 21():191-210. PubMed ID: 32026417
[TBL] [Abstract][Full Text] [Related]
5. Quantitative ligand and receptor binding studies reveal the mechanism of interleukin-36 (IL-36) pathway activation.
Zhou L; Todorovic V; Kakavas S; Sielaff B; Medina L; Wang L; Sadhukhan R; Stockmann H; Richardson PL; DiGiammarino E; Sun C; Scott V
J Biol Chem; 2018 Jan; 293(2):403-411. PubMed ID: 29180446
[TBL] [Abstract][Full Text] [Related]
6. The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab.
Hawkes JE; Visvanathan S; Krueger JG
Front Immunol; 2023; 14():1292941. PubMed ID: 38077370
[TBL] [Abstract][Full Text] [Related]
7. The emergence of the IL-36 cytokine family as novel targets for inflammatory diseases.
Walsh PT; Fallon PG
Ann N Y Acad Sci; 2018 Apr; 1417(1):23-34. PubMed ID: 27783881
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of IL-36 cytokines in folliculitis and eosinophilic pustular folliculitis.
Sato S; Chiba T; Nakahara T; Furue M
Australas J Dermatol; 2020 Feb; 61(1):e39-e45. PubMed ID: 31424098
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-36 in Infectious and Inflammatory Skin Diseases.
Buhl AL; Wenzel J
Front Immunol; 2019; 10():1162. PubMed ID: 31191535
[TBL] [Abstract][Full Text] [Related]
10. Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease.
Andoh A; Nishida A
J Gastroenterol; 2023 Feb; 58(2):69-78. PubMed ID: 36376594
[TBL] [Abstract][Full Text] [Related]
11. Regulation and function of interleukin-36 cytokines.
Bassoy EY; Towne JE; Gabay C
Immunol Rev; 2018 Jan; 281(1):169-178. PubMed ID: 29247994
[TBL] [Abstract][Full Text] [Related]
12. Generalized Pustular Psoriasis: Divergence of Innate and Adaptive Immunity.
Samotij D; Szczęch J; Reich A
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445754
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity.
Towne JE; Renshaw BR; Douangpanya J; Lipsky BP; Shen M; Gabel CA; Sims JE
J Biol Chem; 2011 Dec; 286(49):42594-42602. PubMed ID: 21965679
[TBL] [Abstract][Full Text] [Related]
14. Targeting IL-36 in Inflammatory Skin Diseases.
Fukaura R; Akiyama M
BioDrugs; 2023 May; 37(3):279-293. PubMed ID: 36867370
[TBL] [Abstract][Full Text] [Related]
15. IL-36 in chronic inflammation and cancer.
Neurath MF
Cytokine Growth Factor Rev; 2020 Oct; 55():70-79. PubMed ID: 32540133
[TBL] [Abstract][Full Text] [Related]
16. Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies.
Ganesan R; Raymond EL; Mennerich D; Woska JR; Caviness G; Grimaldi C; Ahlberg J; Perez R; Roberts S; Yang D; Jerath K; Truncali K; Frego L; Sepulveda E; Gupta P; Brown SE; Howell MD; Canada KA; Kroe-Barrett R; Fine JS; Singh S; Mbow ML
MAbs; 2017 Oct; 9(7):1143-1154. PubMed ID: 28726542
[TBL] [Abstract][Full Text] [Related]
17. Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis.
Furue K; Yamamura K; Tsuji G; Mitoma C; Uchi H; Nakahara T; Kido-Nakahara M; Kadono T; Furue M
Acta Derm Venereol; 2018 Jan; 98(1):5-13. PubMed ID: 28967976
[TBL] [Abstract][Full Text] [Related]
18. Spinal IL-36γ/IL-36R participates in the maintenance of chronic inflammatory pain through astroglial JNK pathway.
Li Q; Liu S; Li L; Ji X; Wang M; Zhou J
Glia; 2019 Mar; 67(3):438-451. PubMed ID: 30578562
[TBL] [Abstract][Full Text] [Related]
19. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
[TBL] [Abstract][Full Text] [Related]
20. Biology of IL-36 cytokines and their role in disease.
Gresnigt MS; van de Veerdonk FL
Semin Immunol; 2013 Dec; 25(6):458-65. PubMed ID: 24355486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
